United Kingdom· GB-APID-39292111000001103
Xalkori 250mg capsules
A crizotinib product containing crizotinib, registered in United Kingdom by Originalis B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Crizotinib is registered in 13 of 19 countries.
Countries holding a registration under ATC L01ED01 (crizotinib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Crizotinib · ATC L01ED01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of crizotinib costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Crizotinib · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$203.81
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Crizotinib
- Manufacturer
- Originalis B.V.
- Country
- United Kingdom (GB)
- ATC code
- L01ED01
- ATC class
- Crizotinib
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin8719923005840
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
681 interactions on record for crizotinib.
Graded by severity as the source publishes them — 326 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Crizotinib · interactions on record
681 records
- 326 severe
- 338 moderate
- 17 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Crizotinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaXALKORIPfizer Europe MA EEIG, Bruxelles
- FinlandXALKORIPfizer Europe MA EEIG
- SpainXALKORI 250 MG CAPSULAS DURASPfizer Europe Ma Eeig
- FranceXALKORI 250 mg, gélulePFIZER EUROPE MA EEIG (BELGIQUE)
- IrelandXALKORI 250 mg hard capsulesPfizer Europe MA EEIG
- IcelandXALKORIPfizer Europe MA EEIG*
- NetherlandsXALKORI 250 mg, capsules, hardPfizer Europe MA EEIG
- NorwayXalkoriPfizer Europe MA EEIG (1)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Xalkori
- Liechtenstein · Xalkori
- Norway · Xalkori
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/527aaa3b-6231-4262-a6d7-e260def7b64f GET /v1/drugs/527aaa3b-6231-4262-a6d7-e260def7b64f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39292111000001103",
"desc": "Xalkori 250mg capsules (Originalis B.V.)",
"form": "Oral capsule",
"vpid": "41760811000001108",
"source": "dmd",
"vtm_id": "775398007",
"strength": "250 mg",
"substance": "Crizotinib",
"ingredient": "Crizotinib",
"supplier_code": "36751511000001108"
}See everything about crizotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.